cantor • Latest News

Unknown source / Wed, 17 Jan 2018 23:47:31 GMT
St. Louis Business Journal / Wed, 17 Jan 2018 18:00:42 GMT
Norman Weekly / Wed, 17 Jan 2018 11:47:45 GMT
More sources:
Market Exclusive: Analyst Upgrades – Luxoft (NYSE:LXFT) Stock Gets Upgraded By Cantor Fitzgerald from Neutral to Overweight
Week Herald: Luxoft (LXFT) Upgraded to Overweight by Cantor Fitzgerald
Thorold News / Wed, 17 Jan 2018 17:31:30 GMT
More sources:
Week Herald: AxoGen, Inc. to Post FY2017 Earnings of ($0.31) Per Share, Cantor Fitzgerald Forecasts (AXGN)
Unknown source / Wed, 17 Jan 2018 11:09:39 GMT
More sources:
TrueBlueTribune: Agile Therapeutics' (AGRX) Buy Rating Reaffirmed at Cantor Fitzgerald
The Lincolnian Online: Agile Therapeutics (NASDAQ:AGRX) Rating Reiterated by Cantor Fitzgerald
Dispatch Tribunal: Agile Therapeutics (AGRX) Receives “Buy” Rating from Cantor Fitzgerald